251 related articles for article (PubMed ID: 6615058)
1. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma.
Reintgen DS; Cox EB; McCarty KS; Vollmer RT; Seigler HF
Ann Surg; 1983 Sep; 198(3):379-85. PubMed ID: 6615058
[TBL] [Abstract][Full Text] [Related]
2. Role of elective lymph node dissection in stage I malignant melanoma: evaluation by matched pair analysis.
Rompel R; Garbe C; Büttner P; Teichelmann K; Petres J
Recent Results Cancer Res; 1995; 139():323-36. PubMed ID: 7597301
[TBL] [Abstract][Full Text] [Related]
3. [Elective lymph node dissection in primary malignant melanoma].
Petres J; Rompel R; Büttner P; Teichelmann K; Garbe C
Hautarzt; 1996 Jan; 47(1):29-34. PubMed ID: 8835001
[TBL] [Abstract][Full Text] [Related]
4. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia.
Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
Ann Surg; 1982 Dec; 196(6):677-84. PubMed ID: 7149819
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
6. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
8. The impact of sentinel node dissection on disease-free and overall tumour-specific survival in melanoma patients: a single centre group-matched analysis of 1192 patients.
Geimer T; Sattler EC; Flaig MJ; Ruzicka T; Berking C; Schmid-Wendtner MH; Kunte C
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):629-635. PubMed ID: 27556957
[TBL] [Abstract][Full Text] [Related]
9. The concept of lymph node dissections in patients with malignant melanoma.
Stankard C; Cruse CW; Cox C; Wells KE; King J; Reintgen DS
Ann Plast Surg; 1992 Jan; 28(1):33-8. PubMed ID: 1642404
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial.
Balch CM; Soong S; Ross MI; Urist MM; Karakousis CP; Temple WJ; Mihm MC; Barnhill RL; Jewell WR; Wanebo HJ; Harrison R
Ann Surg Oncol; 2000 Mar; 7(2):87-97. PubMed ID: 10761786
[TBL] [Abstract][Full Text] [Related]
11. The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma.
Crowley NJ; Seigler HF
Cancer; 1990 Dec; 66(12):2522-7. PubMed ID: 2249194
[TBL] [Abstract][Full Text] [Related]
12. Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?
Shen P; Guenther JM; Wanek LA; Morton DL
Ann Surg Oncol; 2000 Mar; 7(2):114-9. PubMed ID: 10761789
[TBL] [Abstract][Full Text] [Related]
13. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
14. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
15. Malignant melanoma. Primary surgical management (excision and node dissection) based on pathology and staging.
Harris MN; Shapiro RL; Roses DF
Cancer; 1995 Jan; 75(2 Suppl):715-25. PubMed ID: 7805000
[TBL] [Abstract][Full Text] [Related]
16. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection.
Cole DJ; Baron PL
Semin Oncol; 1996 Dec; 23(6):719-24. PubMed ID: 8970593
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients.
Milton GW; Shaw HM; McCarthy WH; Pearson L; Balch CM; Soong SJ
Br J Surg; 1982 Feb; 69(2):108-11. PubMed ID: 7059764
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas.
Balch CM; Soong SJ; Smith T; Ross MI; Urist MM; Karakousis CP; Temple WJ; Mihm MC; Barnhill RL; Jewell WR; Wanebo HJ; Desmond R;
Ann Surg Oncol; 2001 Mar; 8(2):101-8. PubMed ID: 11258773
[TBL] [Abstract][Full Text] [Related]
19. Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma unit from 1960 to 1991.
Coates AS; Ingvar CI; Petersen-Schaefer K; Shaw HM; Milton GW; O'Brien CJ; Thompson JF; McCarthy WH
J Am Coll Surg; 1995 Apr; 180(4):402-9. PubMed ID: 7719543
[TBL] [Abstract][Full Text] [Related]
20. Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients.
Drepper H; Köhler CO; Bastian B; Breuninger H; Bröcker EB; Göhl J; Groth W; Hermanek P; Hohenberger W; Lippold A
Cancer; 1993 Aug; 72(3):741-9. PubMed ID: 8334626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]